Peripheral Neuropathy Market to Cross USD 7.23 Billion by 2030: Trends, Challenges, and Opportunities

Peripheral Neuropathy Market

Peripheral Neuropathy Market Is Experiencing Robust Growth, due to Rising Incidence of Diabetes and Rising Drug Development

AUSTIN, TEXAS, UNITED STATES, February 22, 2024 / — The report offers a comprehensive analysis of the peripheral neuropathy market, including its current valuation and projected growth. With a value of USD 3.71 billion in 2022, Global Peripheral Neuropathy Market is anticipated to reach USD 7.23 billion by 2030, experiencing a compound annual growth rate (CAGR) of 8.7% during the forecast period from 2023 to 2030. This growth can be attributed to several factors, including the increasing prevalence of peripheral neuropathy due to factors such as diabetes, chemotherapy, and other underlying medical conditions, the growing adoption of novel therapeutics and treatment modalities, and advancements in diagnostic techniques for early detection and intervention. The report also explores emerging trends in the market, such as the development of targeted therapies and personalized medicine approaches, the rising focus on regenerative medicine and neurostimulation techniques, and the expanding research efforts aimed at understanding the underlying mechanisms of peripheral neuropathy. Additionally, it examines regional dynamics, competitive landscape, and regulatory considerations shaping the market. By providing insights into market size, growth projections, and key trends, the report aims to assist stakeholders in understanding and capitalizing on opportunities in the peripheral neuropathy market.

Market Report Scope & Overview

Peripheral neuropathy refers to a condition characterized by damage to the peripheral nerves, which are responsible for transmitting information between the central nervous system (the brain and spinal cord) and the rest of the body. This disorder can result from various causes, including diabetes, infections, traumatic injuries, autoimmune diseases, and exposure to toxins. The symptoms of peripheral neuropathy can vary widely depending on the nerves affected and the underlying cause. By fostering collaboration among researchers, clinicians, and patients, the peripheral neuropathy market continues to evolve, driving innovation and progress towards more effective prevention, diagnosis, and management strategies.

The scope of peripheral neuropathy market encompasses a broad array of disciplines, including neurology, endocrinology, immunology, and pharmacology, reflecting its multifactorial nature and the need for comprehensive understanding and management strategies. Ongoing research endeavors focus on elucidating the underlying mechanisms of nerve damage, identifying biomarkers for early detection and monitoring, and developing innovative therapeutic interventions to alleviate symptoms and halt disease progression. Advancements in molecular biology, genetics, and imaging techniques have facilitated a deeper understanding of the pathophysiology of peripheral neuropathy, paving the way for targeted treatment approaches and personalized medicine.

Get Sample Report of Peripheral Neuropathy Market:

Major Key Players in the Peripheral Neuropathy Market:

• Abbott Laboratories (United States)

• Bristol Myers Squibb (United States)

• Novartis AG (Switzerland)

• Eli Lilly and Company (United States)

• Pfizer Inc. (United States)

• GlaxoSmithKline plc (United Kingdom)

• Merck & Co., Inc. (United States)

• Cipla Limited (India)

• Lupin Limited (India)

• Dr. Reddy’s Laboratories (India)

Rising Incidence of Chronic Diseases Spurs Peripheral Neuropathy Market Growth: Advances in Diagnostics and Treatments Drive Expansion

The rising incidence of diabetes, chemotherapy usage, and other chronic diseases contributes significantly to the growing peripheral neuropathy market. As these conditions become more prevalent, the pool of patients at risk of developing neuropathic symptoms expands, thereby driving market growth. Advances in diagnostic techniques, such as nerve conduction studies and electromyography, facilitate early and accurate diagnosis of peripheral neuropathy. Additionally, innovations in treatment modalities, including pharmacological interventions and neurostimulation devices, offer novel avenues for managing neuropathic pain and improving patient outcomes, thereby driving market expansion. The continuous rise in healthcare expenditure, particularly in developed regions, enables greater access to diagnostic and treatment options for peripheral neuropathy patients.

Despite the high prevalence of peripheral neuropathy, there remains a lack of awareness among both patients and healthcare providers, leading to underdiagnosis and undertreatment of the condition. This hampers peripheral neuropathy market growth by limiting the patient pool and delaying the adoption of appropriate therapeutic interventions. Advances in our understanding of the pathophysiology of peripheral neuropathy have uncovered novel therapeutic targets, including neuroinflammation and mitochondrial dysfunction. Targeting these mechanisms presents promising opportunities for the development of disease-modifying treatments capable of halting or reversing nerve damage, thereby addressing an unmet need within the market. The growing emphasis on personalized medicine and precision healthcare creates opportunities for the development of tailored therapeutic approaches for peripheral neuropathy patients.

Peripheral Neuropathy Market Segmentation

By Type

• Diabetic Peripheral

• Neuropathy

• Chemotherapy-induced Peripheral Neuropathy

• Idiopathic Peripheral Neuropathy

• HIV/AIDS Associated Peripheral Neuropathy

By Treatment

• Pharmacological Therapies

– Pain Relievers

– Anti-seizure Medications

– Antidepressants

• Non-Pharmacological Therapies

– Transcutaneous Electrical Nerve Stimulation,

– Plasma Exchange

– Intravenous Immune Globulin

• Others

By End User

• Hospitals and Clinics

• Ambulatory Centers

• Others

Make Enquiry About Peripheral Neuropathy Market Report:

Impact of Recession

The ongoing recession can exert both positive and negative effects on the peripheral neuropathy market. On one hand, economic downturns may lead to reduced healthcare spending by individuals and healthcare providers, potentially slowing down market growth. Access to advanced diagnostic technologies and expensive treatments may become more limited, affecting patient care and market demand. On the other hand, during economic downturns, there may be an increased focus on cost-effective healthcare solutions and a greater emphasis on preventive care. This could drive demand for early diagnosis and management of conditions like peripheral neuropathy, thereby positively influencing market dynamics.

Impact of Russia-Ukraine War

The Russia-Ukraine war has the potential to disrupt global markets and economies, which could indirectly impact the peripheral neuropathy market. Instability in geopolitical relations may lead to fluctuations in currency values, trade disruptions, and heightened uncertainties in financial markets. These factors can affect healthcare systems’ ability to procure medical supplies, equipment, and pharmaceuticals, potentially leading to supply chain disruptions for peripheral neuropathy treatments. Furthermore, geopolitical tensions may divert attention and resources away from healthcare priorities, impacting research funding and development efforts in the field of neuropathy.

Regional Analysis

The peripheral neuropathy market exhibits regional variations influenced by factors such as disease prevalence, healthcare infrastructure, regulatory frameworks, and socioeconomic conditions. North America holds a significant share of the market, driven by a high prevalence of diabetes and well-established healthcare systems supporting advanced diagnostics and treatments. Europe follows closely, characterized by a growing aging population and increasing awareness about neuropathic conditions. The Asia-Pacific region presents lucrative opportunities for market expansion due to rising healthcare expenditure, improving access to healthcare services, and a growing patient pool.


SNS Insider’s report on the peripheral neuropathy market provides comprehensive insights into various aspects shaping the industry landscape. The report covers market trends, growth drivers, challenges, and opportunities, offering valuable intelligence for stakeholders including pharmaceutical companies, healthcare providers, investors, and policymakers. Key areas of focus include disease epidemiology, emerging therapeutic trends, regulatory developments, competitive analysis, and market segmentation by product type, distribution channel, and geography.

Buy Peripheral Neuropathy Market Report:

Akash Anand
SNS Insider Pvt. Ltd
+1 415-230-0044
email us here
Visit us on social media:

Originally published at